1. Home
  2. INBX vs III Comparison

INBX vs III Comparison

Compare INBX & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INBX
  • III
  • Stock Information
  • Founded
  • INBX 2010
  • III 2006
  • Country
  • INBX United States
  • III United States
  • Employees
  • INBX N/A
  • III N/A
  • Industry
  • INBX Biotechnology: Pharmaceutical Preparations
  • III Professional Services
  • Sector
  • INBX Health Care
  • III Consumer Discretionary
  • Exchange
  • INBX Nasdaq
  • III Nasdaq
  • Market Cap
  • INBX 178.5M
  • III 207.8M
  • IPO Year
  • INBX 2020
  • III 2007
  • Fundamental
  • Price
  • INBX $21.60
  • III $4.20
  • Analyst Decision
  • INBX Hold
  • III Buy
  • Analyst Count
  • INBX 1
  • III 1
  • Target Price
  • INBX N/A
  • III $5.50
  • AVG Volume (30 Days)
  • INBX 148.3K
  • III 216.1K
  • Earning Date
  • INBX 08-12-2025
  • III 08-06-2025
  • Dividend Yield
  • INBX N/A
  • III 4.29%
  • EPS Growth
  • INBX N/A
  • III N/A
  • EPS
  • INBX 111.58
  • III 0.16
  • Revenue
  • INBX $200,000.00
  • III $242,899,000.00
  • Revenue This Year
  • INBX N/A
  • III N/A
  • Revenue Next Year
  • INBX N/A
  • III $5.08
  • P/E Ratio
  • INBX $0.19
  • III $26.83
  • Revenue Growth
  • INBX N/A
  • III N/A
  • 52 Week Low
  • INBX $10.80
  • III $2.95
  • 52 Week High
  • INBX $25.29
  • III $5.28
  • Technical
  • Relative Strength Index (RSI)
  • INBX 54.33
  • III 31.70
  • Support Level
  • INBX $20.84
  • III $4.21
  • Resistance Level
  • INBX $25.29
  • III $4.60
  • Average True Range (ATR)
  • INBX 1.84
  • III 0.15
  • MACD
  • INBX -0.41
  • III -0.06
  • Stochastic Oscillator
  • INBX 17.17
  • III 4.64

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

About III Information Services Group Inc.

Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.

Share on Social Networks: